Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Js Lee is active.

Publication


Featured researches published by Js Lee.


Journal of Materials Chemistry | 2013

Graphene–Rh-complex hydrogels for boosting redox biocatalysis

Js Lee; Sh Lee Sahng-Ha Lee; Jb Kim Jang-Bae Kim; Cb Park Chan-Beum Park

We report the synthesis of a 3D-structured graphene–Rh-complex hydrogel that works as a robust catalyst for electroenzymatic reactions. When α-ketoglutarate was electroenzymatically converted to L-glutamate in the presence of graphene–Rh-complex hydrogel, the L-glutamate yield increased more than 10 times than that of a free Rh complex.


Gastroenterology | 2003

Experimental interstitial photodynamic therapy of the morris 7777 hepatoma in the rat

Yk Cheon; Ys Kim; Jh Moon; Yd Kim; Sy Jin; Js Lee; Cs Shim

Background : Photodynamic therapy (PDT) of hepatic tumors has been restricted due to the preferential retention of photosensitizers in normal liver tissue. Therefore, superficial tumor illumination causes subsequential liver necrosis. Moreover, the limited light penetration during superficial illumination makes it impossible to treat deep-seated or larger solid tumors. These limitations were overcome by interstitial therapy. Aim: The aim of study is to investigate the macroscopic and microscopic effect of a single session of interstitial photodynamic therapy on liver tumor. Methods : The Morris 7777 hepatoma cells were injected subcutaneously into the flanks of Buffalo female rats. Tumor growth was monitored with measuring the tumor size. Animals were pretreated with hematoporphyrin derivative 48 hours prior to the intratumoral delivery of laser radiation, when the tumor had reached a volume greater than 1.0 . One or two weeks after interstitial PDT, the extent of tumor necrosis was evaluated microscopically. Results : Volume of lesions averaged 10.2 . Histologic stains demonstrated microvascular thrombosis and coagulative necrosis within the lesions. There appeared to be 100% cellular destruction within the lesion by cytochmical staining. Conclusion : The results of this study show the ability of interstitial PDT to cause destruction of liver tumor.


Annals of Oncology | 2016

Ceritinib in ROS1-rearranged non-small-cell lung cancer: a Korean nationwide phase II study

Si-Keun Lim; Byoung Chul Cho; H.R. Kim; Js Lee; K-E Lee; Y-G. Lee; Y.J. Min; Eun Kyung Cho; S-S. Lee; B. T. Kim; M.Y. Choi; H.S. Shim; Jooyoung Chung; Y.L. Choi; Miyoung Lee; M-J. Ahn


Gastroenterology | 2003

Diagnosis of pelvic floor dyssynergia according to the type of attempted defecation during anorectal manometry

Js Lee; Ka Kwon; Hh Im; Kr Hwang; Sh Lee; Gy Jang; Sh Kim Sun-Hwa Kim; Jy Jang; Is Jung; Bm Ko; Sj Hong; Cb Ryu; Jo Kim; J.Y. Cho; Lee; Cs Shim; B. T. Kim


Digestive Disease Week Abstracts & Itinerary Planner | 2003

The comparison of variable methods of endoscopic mucosal resection for early gastric cancer and gastric flat adenoma including insulated tip electrosurgical knife emr

Cb Ryu; Hg Kim; Jy Jang; Bm Ko; Kw Kwon; Sj Hong; Hc Ahn; Jo Kim; J.Y. Cho; Js Lee; Lee; Cs Shim; B. T. Kim


Annals of Oncology | 2017

422PA real world treatment study of osimertinib: ASTRIS study Korean subgroup analysis

Byoung Chul Cho; D-W. Kim; K. Park; Js Lee; S S Yoo; J.H. Kang; Sy. Lee; C H Kim; Seung Hun Jang; Y-C. Kim; H-K Yoon; S. Kim


Annals of Oncology | 2017

410O_PRAlectinib (ALC) vs crizotinib (CRZ) in treatment-naïve ALK+ non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study

T. Mok; S. Peters; D.R. Camidge; S-H.I. Ou; Js Ahn; E.H. Tan; Z Li; Js Lee; Byoung Chul Cho; S L Geater; V Sriuranpong; J Ho; O S-H Chan; Ali Zeaiter; Bogdana Balas; E. Nueesch; E. Mitry; Peter N. Morcos; D-W. Kim


Annals of Oncology | 2017

421PEGFR mutation analysis for prospective patient (pt) selection in AURA3 Phase III trial of osimertinib vs platinum-pemetrexed (plt-pem) in pts with EGFR T790M positive advanced non-small cell lung cancer (NSCLC)

H Akamatsu; A Delmonte; T John; W. Su; Js Lee; G-C Chang; X. Huang; S Jenkins; S Dearden; Y-L. Wu


Annals of Oncology | 2016

468P Osimertinib in patients with T790M mutation positive advanced non-small cell lung cancer (NSCLC): Korean subgroup analysis from pooled phase II data

M-J. Ahn; Js Lee; J. Han; D-W. Kim; Byoung Chul Cho; Jin-Hyoung Kang; S. Kim


Annals of Oncology | 2016

Amethyst NSCLC trial: Phase 2, parallel-arm study of receptor tyrosine kinase (RTK) inhibitor, MGCD265 in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with activating genetic alterations in mesenchymal-epithelial transition factor (MET)

L. Bazhenova; R. Mehra; T. Nagy; L. Cavanna; Js Lee; J. Han; Hyung-Woo Kim; Balazs Halmos; M. Shum; M. Schreeder; I. Rybkin; F. Badin; R. Mena; P.A. Jänne; J. Christensen; V. Tassell; R. Chao; D. Faltaos; D-W. Kim

Collaboration


Dive into the Js Lee's collaboration.

Top Co-Authors

Avatar

B. T. Kim

Sungkyunkwan University

View shared research outputs
Top Co-Authors

Avatar

Jo Kim

Chonnam National University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jy Jang

Chung-Ang University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M-J. Ahn

Samsung Medical Center

View shared research outputs
Top Co-Authors

Avatar

S. Kim

Seoul National University Bundang Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge